Schedule 13G ownership disclosure
Corbus Pharmaceuticals Holdings, Inc.
Security class unavailable · CUSIP: 21833P103
Event date: 2020-12-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,116,550
- Percent of class
- 9.6600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-042180
- Form type
- SC 13G
- Filer
- Corbus Pharmaceuticals Holdings, Inc.
- CIK
- CIK 1595097
- Filed
- Dec 11, 2020
- Reporting period
- Dec 10, 2020
- Description
- Schedule 13G beneficial ownership